Breeze Holdings Acquisition Corp. announced approval of business combination with YD Biopharma Limited.
The combined company will operate as YD Bio Limited and trade on Nasdaq under ticker symbol YDES.
Transaction expected to close in the coming days.
Business Combination Approval
Stockholders approved the Business Combination Proposal with a significant majority.
Ticker Symbol
The combined company will trade on Nasdaq under the ticker symbol YDES.
Closing Timeline
Closing of the transaction expected within the next two weeks.
- YD Bio Limited will enhance its position as a biopharmaceutical company on Nasdaq.
- Approval of the Business Combination Proposal signifies a positive step towards growth and development.
The approval of the business combination and the anticipated trading on Nasdaq under the new ticker symbol YDES mark significant milestones for Breeze Holdings Acquisition Corp. and YD Biopharma Limited, paving the way for future collaborations and advancements in the biopharmaceutical industry.